These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23732144)

  • 21. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.
    Grassi G; Seravalle G; Brambilla G; Mancia G
    Can J Cardiol; 2012 May; 28(3):311-7. PubMed ID: 22244774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
    Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Renal Sympathetic Denervation on Dogs with Pressure Overload-Induced Heart Failure.
    Chen P; Leng S; Luo Y; Li S; Huang Z; Liu Z; Liu Z; Wang J; Lei X
    Heart Lung Circ; 2017 Feb; 26(2):194-200. PubMed ID: 27555054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse consequences of high sympathetic nervous activity in the failing human heart.
    Kaye DM; Lefkovits J; Jennings GL; Bergin P; Broughton A; Esler MD
    J Am Coll Cardiol; 1995 Nov; 26(5):1257-63. PubMed ID: 7594040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal sympathetic denervation: A potential alternative strategy for managing patients with heart failure.
    Lu Y; Zhang L; Zhou X; Tang B
    Int J Cardiol; 2015 Dec; 201():140-1. PubMed ID: 26298357
    [No Abstract]   [Full Text] [Related]  

  • 26. Autonomic modulation for the management of patients with chronic heart failure.
    Schwartz PJ; La Rovere MT; De Ferrari GM; Mann DL
    Circ Heart Fail; 2015 May; 8(3):619-28. PubMed ID: 25991804
    [No Abstract]   [Full Text] [Related]  

  • 27. The human sympathetic nervous system: its relevance in hypertension and heart failure.
    Parati G; Esler M
    Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal sympathetic denervation for treatment of patients with atrial fibrillation: Reappraisal of the available evidence.
    Nammas W; Airaksinen JK; Paana T; Karjalainen PP
    Heart Rhythm; 2016 Dec; 13(12):2388-2394. PubMed ID: 27590432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
    Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
    Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of renal denervation on the development of post-myocardial infarction heart failure and cardiac autonomic nervous system in rats.
    Hu J; Yan Y; Zhou Q; Ji M; Niu C; Hou Y; Ge J
    Int J Cardiol; 2014 Apr; 172(3):e414-6. PubMed ID: 24485639
    [No Abstract]   [Full Text] [Related]  

  • 32. Sympathetic nervous system: role in hypertension and in chronic kidney disease.
    Grassi G; Bertoli S; Seravalle G
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):46-51. PubMed ID: 22080859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of percutaneous renal sympathetic denervation on cardiac function and exercise tolerance in patients with chronic heart failure.
    Gao JQ; Xie Y; Yang W; Zheng JP; Liu ZJ
    Rev Port Cardiol; 2017 Jan; 36(1):45-51. PubMed ID: 27988231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of renal denervation in the treatment of heart failure.
    Sobotka PA; Krum H; Böhm M; Francis DP; Schlaich MP
    Curr Cardiol Rep; 2012 Jun; 14(3):285-92. PubMed ID: 22392370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiorenal axis and arrhythmias: Will renal sympathetic denervation provide additive value to the therapeutic arsenal?
    van Brussel PM; Lieve KV; de Winter RJ; Wilde AA
    Heart Rhythm; 2015 May; 12(5):1080-7. PubMed ID: 25640633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure.
    Han Y; Fu L; Sun W; Cao J; Xie R; Zhou P; Kang N; Sun J
    Eur J Pharmacol; 2009 Oct; 619(1-3):68-74. PubMed ID: 19665014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Doiron JE; Li Z; Yu X; LaPenna KB; Quiriarte H; Allerton TD; Koul K; Malek A; Shah SJ; Sharp TE; Goodchild TT; Kapusta DR; Lefer DJ
    J Am Heart Assoc; 2024 Feb; 13(4):e032646. PubMed ID: 38353216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
    Al-Hesayen A; Parker JD
    Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 40. Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure.
    Kimura K; Kanazawa H; Ieda M; Kawaguchi-Manabe H; Miyake Y; Yagi T; Arai T; Sano M; Fukuda K
    Auton Neurosci; 2010 Aug; 156(1-2):27-35. PubMed ID: 20335077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.